Financials

DNA’s net sales and EBITDA reach record levels in 2019, driven by strong mobile service revenue. 

Financing

Key figures on January 1 - March 31, 2020 (including IFRS 16)

Net debt, MEUR 540.6
Net debt/EBITDA 1.65  (12 month adjusted)
Net gearing, %  93.0
Equity ratio, %  41.7
Average interest of the loan portfolio, %  1.09

 

Primary sources of financing, 31 March 2020

EUR 60 million Bond II, coupon rate 2.875%
EUR 250 million Bond 3, coupon rate 1.375% (see the Prospectus)
EUR 83.1 million EIB
EUR 110 million Intra Group Loans

Financing reserves, 31 March 2020

Amount Utilised
Commercial paper programme of EUR 200 million Not utilized
Intra Group Revolviing Credit Facility EUR 200 million EUR 110 million drawn

DNA’s financial covenants (without IFRS 16)

Equity ratio:
31 March 2020: 41.7%
Limit: 32.7%

Net debt / EBITDA (rolling 12 months):
31 March 2020: 1.75
Limit: 3.77

 

Updated  April 28, 2020